Cure My Disease

Don't miss your cure!

 Log in / Sign up

New registry aims to unlock secrets of rare skin disease morphea

NCT ID NCT01808937

Recruiting now Knowledge-focused Sponsor: University of Texas Southwestern Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is creating a registry of 500 children and adults with morphea (localized scleroderma) to track how the disease behaves over time, what complications arise (like arthritis), and whether it has an autoimmune cause. Participants provide medical history and skin assessments, but no experimental treatment is given. The goal is to gather knowledge to improve future care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this registry could provide a clearer understanding of how morphea progresses and its autoimmune basis, potentially guiding future treatments.
What could go wrong
This is an observational registry, not a treatment trial. It collects data over time and may not lead directly to new therapies. Results depend on participant enrollment and long-term follow-up.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FRONTAL LINEAR SCLERODERMA EN COUP DE SABRE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

linear scleroderma localized scleroderma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FRONTAL LINEAR SCLERODERMA EN COUP DE SABRE MORPHEA SCLERODERMA, CIRCUMSCRIBED SCLERODERMA, LINEAR SCLERODERMA, LOCALIZED

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • UT Southwestern Medical Center - Department of Dermatology

    RECRUITING

    Dallas, Texas, 75390-9069, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.